NEWSROOM
PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix’s HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
NEW YORK, N.Y., July 15, 2024 – PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's (Nasdaq: SNGX) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte™ (synthetic hypericin) is a novel photodynamic therapy for the treatment of early-stage cutaneous T-cell lymphoma (CTCL), a rare form of non-Hodgkin’s lymphoma with no FDA-approved first-line treatments. Highlights from the Q&A:...
Sanwire Corporation Announces Engagement of PCAOB-Registered Auditor and Accounting Firm in Preparation for Filing Form 10 with the SEC
Point Roberts, WA, July 15, 2024 - Sanwire Corporation ("Sanwire" or the "Company") (OTC: SNWR), a diversified company with a focus on aggregating technologies within a number of industries, is pleased to announce that it has retained Fruci & Associates II, PLLC (“Fruci”), a PCAOB-registered accounting and auditing firm to conduct a two-year audit of the Company’s financial statements. Upon audit completion, the Company intends to file Form 10 with the Securities and Exchange Commission...
SKYX Announces Production of its New Global Patented Advanced, Smart, Plug & Play Recessed Light
The Global Recessed Light Market is a Multi-Billion Unit Market As SKYX Continues to Grow its Market Penetration it Expects its Recessed Light to Significantly Contribute to Growth SKYX’s New Plug & Play Recessed Light Global Patents include the U.S., China, Canada, Hong-Kong and Mexico Miami, FL, July 11, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 94 issued and pending...
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in “Take Advantage of the Moment” Episode
HOLLAND, Mich., July 11, 2024 – MedTech Gurus, a leading podcast focused on the forefront of medical technology, featured Oncocyte Corporation (NASDAQ: OCX) CEO Josh Riggs in its latest episode, "Take Advantage of the Moment." In this episode, Riggs highlights Oncocyte's innovative strategies in molecular diagnostic technology and the significant impact of this technology on patient care. Hosted by Tom Hickey, a partner at Excelerant Consulting and a seasoned expert in medical device...
SMC Announces Retirement of Additional $436,884 of Debt
Boca Raton, FL, July 11, 2024 - SMC Entertainment, Inc. ("SMC" or the "Company") (OTC: SMCE), a versatile incubator company focused on acquisition and support of proven commercialized financial services and technology (Fintech) companies, is pleased to announce the retirement of an additional $436,884 of debt in the form of consulting fees and management conversion of accrued earnings (the “Debt”). The Debt retirement will be reflected in the Company's third quarter 2024 financial statements....
CORRECTING and REPLACING – Sono-Tek Reports 40% Increase in Sales and 525% Increase in Net Income for First Quarter Fiscal 2025
Provides Sales Guidance for Second Quarter of Fiscal 2025 and Anticipates Continued Sales Growth for Fiscal 2025 MILTON, N.Y., July 11, 2024 – Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its first quarter of fiscal year 2025, ended May 31, 2024. First Quarter FY2025 Financial Highlights: (Compared with prior-year period unless otherwise noted) Net Sales for the quarter increased 40% to...
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns
LAS VEGAS, NEVADA, July 10, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a leader in artificial intelligence (AI) technology specializing in cutting edge AI and data center infrastructure solutions, today announced its planned state-of-the-art data centers, outfitted with immersible AI supercomputer servers, will address a number of unmet needs in the AI and big data industry’s rapid growth, while answering key sustainability and infrastructure concerns arising in...
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
POMPANO BEACH, FL, July 10, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved a clinical study to evaluate AmnioWrap2™ (AW2) in diabetic foot ulcers (DFU), one of the company’s placental-derived allograft commercial products. Jason Matuszewski, CEO of BioStem, commented: “Diabetic foot ulcers are a...
Neon Bloom Changes Course With New Leadership and Divestment of Bazelet™
Recent Acquisition Leads to New Management and Expanding Focus On Financial Services Sector NEWPORT BEACH, CA, July 9, 2024 - Neon Bloom, Inc. (OTC PINK: NBCO), announced today that it has divested itself of its subsidiary, Bazelet™ Health Systems Inc. in a shift in the Company’s direction away from the HealthTech sector following the acquisition of Advanced Executive Sales, LLC (AES). Following the acquisition of AES, the Company added an additional Director, Mr. Anthony Bianchi Esq., who...
American Shared Hospital Services Announces Signing of Joint Venture Agreement for Gamma Knife Facility in Guadalajara, Mexico
JV will Establish Company’s 4th International Center SAN FRANCISCO, CA, July 9, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that it has signed a joint venture agreement to partner in a Gamma Knife treatment facility in Guadalajara, Mexico. AMS has signed a Joint Venture (“JV”) agreement with Hospital San...